,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #ffgj  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,may #a1 #bjbj,ms4    
,e%oo 7= h]self & ,mrs4 ,brooks (       
,indiana7 introduc$ ! foll[+ bill2 :i* 0
 ref]r$ to ! ,committee on ,en]gy &     
,comm]ce  ,a ,,bill  ,to provide = an   
exploration ( /rategies to increase     
dome/ic manufactur+ & div]sify ! supply 
*a9 ( critical drugs1 & = o!r purposes4 
#a4 ,%ort title ,?is ,act may be cit$ z 
! ,prescription = ,am]ican ,drug        
,indep5d5ce ,act ( #bjbj4  #b4 ,national
 ,academies /rategies ,to increase      
dome/ic manufactur+ ( critical drugs    
7a7 ,9 g5]al ,n lat] ?an #ad days aft] !
 date ( enactm5t ( ?is ,act1 ! ,secret>y
 ( ,heal? & ,human ,s]vices %all ent]   
into an agreem5t ) ! ,national          
,academies ( ,sci5ces1 ,eng9e]+1 &      
,m$ic9e 7ref]r$ to 9 ?is section z !    
,national ,academies7 "u :i*1 n lat] ?an
 #ij days aft] ! date ( ent]+ into !    
agreem5t1 ! ,national ,academies w--    
7#a7 e/abli% a committee ( exp]ts :o are

 kn[l$geable ab\t drug supply issues1   
includ+-- 7,a7 s\rc+ & production (     
critical drugs2  7,b7 s\rc+ & production
 ( active ph>maceutical +r$i5ts 9       
critical drugs2  7,c7 ! raw mat]ials &  
o!r compon5ts = critical drugs2 &  7,d7 
! public heal? & national security      
implications ( ! curr5t supply *a9 =    
critical drugs2  7#b7 conv5e a public   
symposium to-- 7,a7 analyze ! impact (  
,unit$ ,/ates dep5d5ce on ! =eign       
manufactur+ ( critical drugs on pati5t  
access & c>e1 includ+ 9 hospitals &     
int5sive c>e units2 &  7,b7 recomm5d    
/rategies to end ,unit$ ,/ates dep5d5ce 
on =eign manufactur+ to ensure ! ,unit$ 
,/ates has a div]se & vital supply *a9 =
 critical drugs to protect ! ,nation f  
natural or ho/ile occurr5ces2 &  7#c7   
submit a report on ! symposium's        
proce$+s to ! ,congress & publi% a      
summ>y ( su* proce$+s on ! public       
website ( ! ,national ,academies4  7b7  
,symposium ,9 c>ry+ out ! agreem5t "u   
subsection 7a71 ! ,national ,academies  

%all consult )-- 7#a7 ! ,dep>tm5t (     
,heal? & ,human ,s]vices1 ! ,dep>tm5t ( 
,homel& ,security1 ! ,dep>tm5t (        
,def5se1 ! ,dep>tm5t ( ,comm]ce1 !      
,dep>tm5t ( ,/ate1 ! ,dep>tm5t (        
,vet]ans ,affairs1 ! ,dep>tm5t (        
,ju/ice1 & any o!r ,f$]al ag5cies z     
appropriate2 &  7#b7 relevant           
/akehold]s1 includ+ drug manufactur]s1  
heal? c>e provid]s1 m$ical pr(essional  
societies1 ,/ate-bas$ societies1 public 
heal? exp]ts1 ,/ate & local public heal?
 dep>tm5ts1 ,/ate m$ical bo>ds1 pati5t  
gr\ps1 heal? c>e di/ributors1 :olesal]s 
& gr\p pur*as+ organizations1 ph>maci/s1
 & o!r entities ) exp]i5ce 9 heal? c>e &
 public heal?1 z appropriate4  7c7      
,def9itions ,= ! purposes ( ?is section3
 7#a7 ,! t]m critical drug means a drug 
t is describ$ 9 subsection 7a7 ( section
 #ejf;,c ( ! ,f$]al ,food1 ,drug1 &     
,cosmetic ,act 7#ba ,u4,s4,c4 #cef;c7   
7relat+ to notification ( any           
discont9uance or int]ruption 9 !        
production ( life-sav+ drugs74  7#b7 ,! 

t]m drug has ! mean+ giv5 to su* t]m 9  
section #bja ( ! ,f$]al ,food1 ,drug1 & 
,cosmetic ,act 7#ba ,u4,s4,c4 #cba74